Effectiveness of ramelteon for insomnia symptoms in older adults with obstructive sleep apnea: A randomized placebo-controlled pilot study

Journal of Clinical Sleep Medicine

Volumn 6, Issue 6, 2010, Pages 572-580

  Gooneratne, Nalaka S ^a   Gehrman, Philip ^a,b   Gurubhagavatula, Indira ^a,c   Al Shehabi, Erica ^a   Marie, Elisabeth ^a   Schwab, Richard ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Aged; APAP; Insomnia; Polysomnography; Ramelteon; Sleep apnea

Indexed keywords

PLACEBO; RAMELTEON;

AGED; APNEA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HYPOPNEA INDEX; INSOMNIA; MALE; POLYSOMNOGRAPHY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SLEEP APNEA SYNDROME;

EID: 78751686894     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.27991     Document Type: Article

References (50)

1. Young T, Shahar E, Nieto FJ, et al. Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 2002;162:893-900. (Pubitemid 34299121)
2. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002;6:97-111.
3. Beneto A, Gomez-Siurana E, Rubio-Sanchez P. Comorbidity between sleep apnea and insomnia. Sleep Med Rev 2009.
4. Johansson P, Alehagen U, Svanborg E, Dahlstrom U, Brostrom A. Sleep disordered breathing in an elderly community-living population: Relationship to cardiac function, insomnia symptoms and daytime sleepiness. Sleep Med 2009;10:1005-11.
5. Lichstein KL, Riedel BW, Lester KW, Aguillard RN. Occult sleep apnea in a recruited sample of older adults with insomnia. J Consult Clin Psychol 1999;67:405-10.
6. Krakow B, Melendrez D, Ferreira E, et al. Prevalence of insomnia symptoms in patients with sleep-disordered breathing. Chest 2001;120:1923-9. (Pubitemid 34053455)
7. Chung KF. Relationships between insomnia and sleep-disordered breathing. Chest 2003;123:310-1; author reply 311-3.
8. Chung KF. Insomnia subtypes and their relationships to daytime sleepiness in patients with obstructive sleep apnea. Respiration 2005;72:460-5.
9. Mendelson WB, Garnett D, Gillin JC. Flurazepam-induced sleep apnea syndrome in a patient with insomnia and mild sleep-related respiratory changes. J Nerv Ment Dis 1981;169:261-4. (Pubitemid 11156021)
10. Berry RB, Kouchi K, Bower J, Prosise G, Light RW. Triazolam in patients with obstructive sleep apnea. Am J Respir Crit Care Med 1995;151:450-4.
11. Berry RB, Patel PB. Effect of Zolpidem on the efficacy of continuous positive airway pressure as treatment for obstructive sleep apnea. Sleep 2006;29:1052-6.
12. Sateia MJ, Hauri P, Kripke D, Roehrs T. Clinical safety of flurazepam and midazolam during 14-day use in chronic insomniacs. J Clin Psychopharmacol 1990;10:28S-31S. (Pubitemid 20316978)
13. Camacho ME, Morin CM. The effect of temazepam on respiration in elderly insomniacs with mild sleep apnea. Sleep 1995;18:644-5.
14. Neutel CI, Perry S, Maxwell C. Medication use and risk of falls. Pharmacoepidemiol Drug Saf 2002;11:97-104.
15. Smith S, Sullivan K, Hopkins W, Douglas J. Frequency of insomnia report in patients with obstructive sleep apnoea hypopnea syndrome (OSAHS). Sleep Med 2004;5:449-56. (Pubitemid 39194054)
16. Cherniack NS. Sleep apnea and insomnia: sleep apnea plus or sleep apnea minus. Respiration 2005;72:458-9.
17. Guilleminault C, Davis K, Huynh NT. Prospective randomized study of patients with insomnia and mild sleep disordered breathing. Sleep 2008;31:1527-33.
18. Krakow B, Melendrez D, Lee SA, Warner TD, Clark JO, Sklar D. Refractory insomnia and sleep-disordered breathing: a pilot study. Sleep Breath 2004;8:15-29. (Pubitemid 38489448)
19. Krakow B, Melendrez D, Sisley B, et al. Nasal dilator strip therapy for chronic sleep-maintenance insomnia and symptoms of sleep-disordered breathing: a randomized controlled trial. Sleep Breath 2006;10:16-28. (Pubitemid 44193433)
20. Kryger M, Wang-Weigand S, Roth T. Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea. Sleep Breath 2007;11:159-64. (Pubitemid 47307844)
21. American Academy of Sleep Medicine. International classification of sleep disorders, 2nd ed.: Diagnostic and coding manual. Westchester, IL: American Academy of Sleep Medicine; 2005.
22. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22:667-89.
23. American Psychiatric Association. Diagnostic and statistical manual of mental disorders : DSM-IV-TR. 4th ed. Washington DC: American Psychiatric Association; 2000.
24. Buchsbaum DG, Buchanan RG, Welsh J, Centor RM, Schnoll SH. Screening for drinking disorders in the elderly using the CAGE questionnaire. J Am Geriatr Soc 1992;40:662-5.
25. Folstein M, Folstein S, McHugh P. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 1975;12:189-198.
26. Rechtschaffen A, Kales A. A manual of standardization terminology: techniques and scoring system for sleep stages of human subjects. Los Angeles: Brain Information Services/Brain Research Institute, University of California at Los Angeles; 1968.
27. Konermann M, Sanner BM, Vyleta M, et al. Use of conventional and self-adjusting nasal continuous positive airway pressure for treatment of severe obstructive sleep apnea syndrome: a comparative study. Chest 1998;113:714-8.
28. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213.
29. Dolberg OT, Hirschmann S, Grunhaus L. Melatonin for the treatment of sleep disturbances in major depressive disorder. Am J Psychiatry 1998;155:1119-21. (Pubitemid 28357744)
30. Bastien CH, Vallieres A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med 2001;2:297-307. (Pubitemid 32677404)
31. Johns MW. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 1992;15:376-81.
32. Chervin R, Aldrich M, Pickett R, Guilleminault C. Comparison of the results of the Epworth Sleepiness Scale and the Multiple Sleep Latency Test. J. Psychosomatic Res 1997;42:145-55. (Pubitemid 27129493)
33. Weaver TE, Laizner AM, Evans LK, et al. An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep 1997;20:835-43.
34. Ware J, Sherborne C. The MOS-36 item short form health survey (SF-36): I. conceptual framework and item selection. Med Care 1992;30:473-481.
35. Lyons RA, Perry HM, Littlepage BN. Evidence for the validity of the Short-form 36 Questionnaire (SF-36) in an elderly population. Age Ageing 1994;23:182-4.
36. Miller MD, Paradis CF, Houck PR, et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 1992;41:237-48.
37. Effect Size Calculator [Computer program]. Centre for Evaluation and Monitoring, Durham University; 2006. Available at: http://www.cemcentre.org/ renderpage.asp?linkID=30325017.
38. Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001;285:1987-91. (Pubitemid 32366951)
39. Vgontzas AN, Zoumakis M, Bixler EO, et al. Impaired nighttime sleep in healthy old versus young adults is associated with elevated plasma interleukin-6 and cortisol levels: physiologic and therapeutic implications. J Clin Endocrinol Metab 2003;88:2087-95.
40. Ohayon MM, Carskadon MA, Guilleminault C, Vitiello MV. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep 2004;27:1255-73. (Pubitemid 44138893)
41. Bonnet MH. The effect of sleep fragmentation on sleep and performance in younger and older subjects. Neurobiol Aging 1989;10:21-5.
42. Youngstedt SD, Kripke DF, Elliott JA, Klauber MR. Circadian abnormalities in older adults. J Pineal Res 2001;31:264-72.
43. Katz DA, McHorney CA. Clinical correlates of insomnia in patients with chronic illness. Arch Intern Med 1998;158:1099-107.
44. Avidan AY. Sleep in the geriatric patient population. Semin Neurol 2005;25:52-63.
45. Gooneratne NS, Gehrman PR, Nkwuo JE, et al. Consequences of comorbid insomnia symptoms and sleep-related breathing disorder in elderly subjects. Arch Intern Med 2006;166:1732-8.
46. Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kales A. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 1998;157:144-8.
47. Unruh ML, Redline S, An MW, et al. Subjective and objective sleep quality and aging in the Sleep Heart Health Study. J Am Geriatr Soc 2008;56:1218-1227.
48. Mini LJ, Wang-Weigand S, Zhang J. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty. Am J Geriatr Pharmacother 2007;5:177-84. (Pubitemid 350048506)
49. Reynoldson JN, Elliott E Sr, Nelson LA. Ramelteon: a novel approach in the treatment of insomnia. Ann Pharmacother 2008;42:1262-71.
50. Lettieri CJ, Shah AA, Holley AB, Kelly WF, Chang AS, Roop SA. Effects of a short course of eszopiclone on continuous positive airway pressure adherence: a randomized trial. Ann Intern Med 2009;151:696-702.